Kelonia Therapeutics
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform. The company's cutting-edge in vivo gene delivery technology is simple and elegant, relying on a few potent lentiviral vector-like particles to precisely and efficiently deliver genetic cargo to the desired target tissue, and only that tissue, every time. To deliver genetic cargo only to the desired tissue, the lentiviral vector gene delivery platform employs a simple and elegant solution based on decades of research, development, and technical experience. Kelonia's mission is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.
Domain
keloniatx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$50.0M
Founded
2016
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does Kelonia Therapeutics use?+
Kelonia Therapeutics uses 16 technologies including jsDelivr, WordPress, Divi.
What industry is Kelonia Therapeutics in?+
Kelonia Therapeutics operates in the Biotechnology industry.
Where is Kelonia Therapeutics based?+
Kelonia Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026